Free shipping on all orders over $ 500

Teprotumumab

Cat. No. M24540

All AbMole products are for research use only, cannot be used for human consumption.

Teprotumumab Structure
Synonym:

RV001; R1507

Size Price Availability Quantity
100ug USD 150  USD150 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Teprotumumab (RV001, R1507) is a first-in-class IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research.

Chemical Information
CAS Number 1036734-93-6
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Tina Nie, et al. Drugs. Teprotumumab: A Review in Thyroid Eye Disease

[2] Raymond S Douglas, et al. Ophthalmology. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study

[3] No authors listed. Teprotumumab

[4] Raymond S Douglas, et al. N Engl J Med. Teprotumumab for the Treatment of Active Thyroid Eye Disease

[5] Terry J Smith, et al. N Engl J Med. Teprotumumab for Thyroid-Associated Ophthalmopathy

Related IGF-1R Products
Indirubin Derivative E804 

Indirubin Derivative E804 is a potent inhibitor of Insulin-like Growth Factor 1 Receptor (IGF1R), with an IC50 of 0.65 μM for IGF1R.

IGF-I (24-41)

IGF-I (24-41) (Insulin-like Growth Factor I (24-41)) is amino acids 24 to 41 fragment of IGF-I.

GIP, human

GIP, human is a peptide hormone consisting of 42 amino acids that also acts as a promoter of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. In addition, GIP, human acts as an enteric proinsulin hormone released by intestinal K cells in response to nutrient intake.

VMB-100

VMB-100 is an engineered mRNA molecule encoding human insulin-like growth factor-1 (IGF-1) that induces IGF-1 expression in human muscle cells.

NBI-31772 hydrate 

NBI-31772 hydrate is a potent inhibitor of interaction between insulin-like growth factor (IGF) and IGF-binding proteins (IGFBPs). NBI-31772 hydrate is also a nonpeptide ligand that releases bioactive IGF-I from the IGF-I/IGFBP-3 complex (Kis=1-24 nM for all six human subtypes). Anxiolytic and antidepressant-like effects.

  Catalog
Abmole Inhibitor Catalog




Keywords: Teprotumumab, RV001; R1507 supplier, IGF-1R, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.